CAR-T Therapy Tested in Pre-Cancer State Shows Promise for Prevention Strategy

References

1. 1.Blackadar, C. B. (2016). Historical review of the causes of cancer. World Journal of Clinical Oncology, 7(1), 54-86. https://doi.org/10.5306/wjco.v7.i1.54
2. 2.Chen, A., Garde, D., & Herper, M. (2026, April 20). At AACR, a provocative use of CAR-T, Merck's new thing and cancer's geography problem. STAT News. https://www.statnews.com/2026/04/20/aacr-2026-car-t-multiple-myeloma-merck-rural-health-ai/
3. 3.Hanahan, D. (2022). Hallmarks of cancer: new dimensions. Cancer Discovery, 12(1), 31-46. https://doi.org/10.1158/2159-8290.CD-21-1059
4. 4.Kumar, S., Paiva, B., Anderson, K. C., et al. (2016). International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. The Lancet Oncology, 17(8), e328-e346. https://doi.org/10.1016/S1470-2045(16)30206-6
5. 5.Kyle, R. A., Remstein, E. D., Therneau, T. M., et al. (2007). Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. New England Journal of Medicine, 356(25), 2582-2590. https://doi.org/10.1056/NEJMoa070389
6. 6.Lakshman, A., Rajkumar, S. V., Buadi, F. K., et al. (2018). Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria. Blood Cancer Journal, 8(6), 59. https://doi.org/10.1038/s41408-018-0077-4
7. 7.Mateos, M. V., Kumar, S., Dimopoulos, M. A., et al. (2020). International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM). Blood Cancer Journal, 10(10), 102. https://doi.org/10.1038/s41408-020-0370-1
8. 8.Munshi, N. C., Anderson, L. D., Shah, N., et al. (2021). Idecabtagene vicleucel in relapsed and refractory multiple myeloma. New England Journal of Medicine, 384(8), 705-716. https://doi.org/10.1056/NEJMoa2024850
9. 9.Santomasso, B. D., Park, J. H., Salloum, D., et al. (2018). Clinical and biological correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute lymphoblastic leukemia. Cancer Discovery, 8(8), 958-971. https://doi.org/10.1158/2159-8290.CD-17-1319